Home/Filings/4/0001225208-17-004922
4//SEC Filing

BOSTON SCIENTIFIC CORP 4

Accession 0001225208-17-004922

$BSXCIK 0000885725operating

Filed

Feb 27, 7:00 PM ET

Accepted

Feb 28, 4:46 PM ET

Size

8.1 KB

Accession

0001225208-17-004922

Insider Transaction Report

Form 4
Period: 2017-02-27
Dawkins Keith D
Sr. VP, Chief Medical Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2017-02-27+4,77783,996 total
  • Tax Payment

    Common Stock

    2017-02-27$24.81/sh1,546$38,35682,450 total
  • Exercise/Conversion

    Deferred Stock Units

    2017-02-274,7779,472 total
    Common Stock (4,777 underlying)
Footnotes (3)
  • [F1]Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
  • [F2]Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 27, 2013, the first anniversary of the date of grant.
  • [F3]Reflects multiple DSU awards with independent vesting schedules.

Documents

1 file

Issuer

BOSTON SCIENTIFIC CORP

CIK 0000885725

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0000885725

Filing Metadata

Form type
4
Filed
Feb 27, 7:00 PM ET
Accepted
Feb 28, 4:46 PM ET
Size
8.1 KB